| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in TARS over the last quarter tilts toward selling: insiders offloaded a net 62,595 shares worth roughly $5.2M.
TARS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 828.0K | $75.57M | - | |
| Dir | 95.3K | $7.47M | - | |
| COO | 78.5K | $6.68M | - | |
| Other | 64.0K | $4.29M | - | |
| Other | 61.5K | $4.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | Greenstein Leonard M. | Chief Financial Officer | Sell | 5,000 | $16.03 | $80,150.00 | -7.8% | -6.1% | +1.1% | |
| Sep 14, 2022 | Azamian Bobak R.45 | President And CEO | Sell | 9,000 | $16.01 | $144,090.00 | -0.8% | -6.8% | -9.3% | |
| Sep 14, 2022 | Lin Elizabeth Yeu | Director | Buy | 18,400 | $16.12 | $296,605.60 | -152.8% | -6.8% | -9.3% | |
| Aug 18, 2022 | Greenstein Leonard M. | Chief Financial Officer | Sell | 5,000 | $16.30 | $81,500.00 | -7.2% | +3.1% | +4.5% | |
| Aug 17, 2022 | Azamian Bobak R.45 | President And CEO | Sell | 8,000 | $16.59 | $132,691.84 | -0.7% | +7.0% | -1.0% | |
| May 5, 2022 | Vivo Capital Ix, LLC57 | 10% Owner | Sell | 5,374 | $12.25 | $65,831.50 | -0.2% | +42.7% | +27.4% | |
| May 5, 2022 | Ackermann Michael76 | Director | Buy | 100,000 | $13.50 | $1,350,000.00 | New | +42.7% | +27.4% | |
| May 4, 2022 | Vivo Capital Ix, LLC57 | 10% Owner | Sell | 512,956 | $13.39 | $6,866,310.96 | -17.2% | +28.9% | +16.8% | |
| Dec 1, 2021 | Azamian Bobak R.45 | President And CEO | Sell | 5,833 | $24.72 | $144,166.82 | -0.5% | -21.4% | -30.4% | |
| Dec 1, 2021 | Ackermann Michael76 | Director | Sell | 5,833 | $24.68 | $143,934.45 | -0.5% | -21.4% | -30.4% |